Blood culture, a procedure that takes several days, is still the standard to diagnose sepsis patients. As a result, these patients often receive inappropriate or delayed treatment. A new assay based on SMOLT will resolve this problem by providing actionable results in one hour.
Learn MoreBecause SMOLT does not need to amplify nucleic acids before detecting them, it enables entirely new diagnostic possibilities. Scanogen is utilizing SMOLT technology to develop assays that are faster, more sensitive, robust, and cost-effective than available systems.
Learn More